GO:1904141 positive regulation of microglial cell migration: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904141 describes any process that activates or increases the frequency, rate or extent of microglial cell migration, a key step in neuroinflammation and brain repair [1,5].
• Microglial migration is driven by chemokines, growth factors, and damage-associated signals that converge on cytoskeletal remodeling and integrin adhesion [2,5].
• Key regulators include CSF1R, LILRB4, KLF4/BIG1, SET8, ADAM8, and Na+/H+ exchanger isoform 1, which modulate PI3K/Akt, NF-kB, and MAPK signaling [1,2,3,5,7,8].
• Dysregulated microglial migration contributes to ischemic stroke, Alzheimer's disease, spinal cord injury, retinal degeneration, and glioma progression [1,3,6,7,8].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate genes in microglial migration [1,2,5].
• EDITGENE provides end-to-end CRISPR cell model generation and CRISPR library screening to accelerate target discovery in neuroinflammation.
Description
Microglia are the resident immune cells of the central nervous system and their directed migration toward sites of injury, infection, or protein aggregation is a fundamental component of neuroinflammation and tissue surveillance [1,5]. The Gene Ontology term GO:1904141, positive regulation of microglial cell migration, captures any molecular event that activates or increases the frequency, rate, or extent of this migratory behavior [1,5]. Understanding this process is essential because microglial positioning determines whether the brain mounts a protective or pathological immune response [1,3]. Mechanistically, positive regulation of microglial cell migration integrates chemokine gradients, growth factor receptor signaling, and adhesion dynamics that ultimately remodel the actin cytoskeleton [2,5]. For example, lipopolysaccharide (LPS) stimulates BV2 microglial migration by decreasing SET8 expression, which relieves epigenetic repression of pro-migratory genes. Similarly, the KLF4/BIG1 axis regulates LPS-mediated neuroinflammation and migration through PI3K/Akt/NF-kB signaling. These findings establish GO:1904141 as a convergence point for inflammatory and epigenetic inputs [2,5]. From a translational perspective, positive regulation of microglial cell migration is implicated in acute ischemic stroke, Alzheimer's disease, spinal cord injury, retinal degeneration, and glioma progression [1,3,6,7,8]. For instance, microglial LILRB4 upregulation reduces brain damage after acute ischemic stroke by limiting CD8+ T cell recruitment, a process that depends on controlled microglial motility. Soluble CSF1R promotes microglial activation and amyloid clearance in Alzheimer's disease, highlighting how migratory regulation can be harnessed for therapeutic benefit. Consequently, researchers need robust CRISPR models to dissect which genes causally drive GO:1904141 in specific disease contexts [1,2,5].
positive regulation of microglial cell migration At A Glance
| GO ID | GO:1904141 |
|---|---|
| GO term | positive regulation of microglial cell migration |
| Ontology | biological_process |
| Synonym | activation of microglial cell migration; up regulation of microglial cell migration; up-regulation of microglial cell migration; upregulation of microglial cell migration |
| Major function | Enhances the frequency, rate, or extent of microglial cell migration during neuroinflammation, injury, and surveillance [1,5] |
| Key upstream signals | LPS, chemokines, CSF1R, LILRB4, KLF4/BIG1, SET8, ADAM8, Na+/H+ exchanger isoform 1 [1,2,3,5,7,8] |
| Associated diseases | Ischemic stroke, Alzheimer's disease, spinal cord injury, retinal degeneration, glioma [1,3,6,7,8] |
| Research models | BV2 microglial cells, primary microglia, CRISPR KO/knock-in/overexpression, in vivo stroke and glioma models [1,2,5,8] |
What Is GO:1904141?
GO:1904141, positive regulation of microglial cell migration, is defined as any process that activates or increases the frequency, rate, or extent of microglial cell migration [1,5]. In practical terms, it encompasses signaling events, transcriptional changes, and cytoskeletal rearrangements that enhance the ability of microglia to move through brain parenchyma toward chemoattractant gradients [2,5].
Why Is positive regulation of microglial cell migration Important in Cell Biology?
Positive regulation of microglial cell migration is important because the speed and direction of microglial movement directly influence the balance between neuroprotection and neurotoxicity [1,3]. In acute ischemic stroke, microglial LILRB4 upregulation reduces brain damage by limiting CD8+ T cell recruitment, a process that requires regulated microglial motility. In Alzheimer's disease, soluble CSF1R promotes microglial activation and amyloid clearance, demonstrating that enhancing specific migratory programs can be therapeutically beneficial. Conversely, excessive or misdirected migration can exacerbate neuroinflammation in spinal cord injury and retinal degeneration [6,7]. Therefore, identifying the genes that positively regulate microglial migration is a prerequisite for developing targeted interventions [2,5,8].
• Microglial migration is a first responder mechanism in ischemic stroke, Alzheimer's disease, spinal cord injury, and retinal degeneration [1,3,6,7].
• Positive regulation of migration determines the speed of microglial accumulation at injury sites and the subsequent inflammatory cascade [1,5].
• CSF1R signaling enhances microglial activation and amyloid clearance, linking migratory regulation to therapeutic amyloid removal.
• LILRB4 upregulation on microglia reduces brain damage after stroke by limiting CD8+ T cell recruitment.
• KLF4/BIG1 controls LPS-mediated neuroinflammation and migration via PI3K/Akt/NF-kB, providing druggable nodes.
• SET8 downregulation is a mechanism by which LPS induces BV2 microglial migration.
• ADAM8-Fra-1 complex blockade attenuates neuroinflammation by suppressing the Map3k4/MAPKs axis after spinal cord injury.
• Na+/H+ exchanger isoform 1 mediates glioma-induced microglial activation and migration, promoting glioma proliferation.
• Müller cell-regulated microglial activation and migration occur in N-methyl-N-nitrosourea-induced retinal degeneration.
• CRISPR-based causal screens can identify which of these regulators are truly required for GO:1904141 in disease models [1,2,5].
What Happens During positive regulation of microglial cell migration?
Initiation by Chemoattractant and Inflammatory Signals
In simple terms: Microglia start moving when they sense danger signals or chemical trails.
Positive regulation of microglial cell migration begins when extracellular cues such as LPS, chemokines, or damage-associated molecular patterns engage surface receptors on microglia [2,5]. LPS treatment of BV2 microglial cells induces migration via a decrease in SET8 expression, indicating that epigenetic derepression is an early step. Similarly, the KLF4/BIG1 axis regulates LPS-mediated neuroinflammation and migration through PI3K/Akt/NF-kB signaling, linking inflammatory receptor activation to pro-migratory gene expression. In glioma, Na+/H+ exchanger isoform 1 mediates microglial activation and migration, showing that tumor-derived signals can also initiate this program.
Signal Transduction Through PI3K/Akt, NF-kB, and MAPK
In simple terms: Inside the cell, a relay of signaling proteins amplifies the migration command.
Once initiated, positive regulation of microglial cell migration depends on intracellular signaling cascades [2,7]. The KLF4/BIG1 complex regulates LPS-mediated migration via PI3K/Akt/NF-kB signaling in BV2 cells. In spinal cord injury, blockade of the ADAM8-Fra-1 complex attenuates neuroinflammation by suppressing the Map3k4/MAPKs axis, demonstrating that MAPK signaling is a positive regulator of microglial migratory behavior. These pathways converge on transcription factors that drive expression of cytoskeletal and adhesion molecules needed for movement [2,7].
Cytoskeletal Remodeling and Adhesion Dynamics
In simple terms: The cell's internal skeleton rearranges so it can push forward and grip the surface.
The execution phase of positive regulation of microglial cell migration requires actin polymerization, myosin contraction, and integrin-mediated adhesion [5,8]. LPS-induced SET8 downregulation in BV2 microglial cells promotes migration, which involves reorganization of the actin cytoskeleton. Na+/H+ exchanger isoform 1 activity supports glioma-mediated microglial activation and migration, likely by regulating intracellular pH and cytoskeletal dynamics. These events allow microglia to extend lamellipodia and translocate toward the chemoattractant source [5,8].
Resolution and Feedback by LILRB4 and CSF1R
In simple terms: The migration response is tuned by inhibitory and stimulatory receptors so it does not go out of control.
Positive regulation of microglial cell migration is balanced by modulatory receptors [1,3]. Microglia LILRB4 upregulation reduces brain damage after acute ischemic stroke by limiting CD8+ T cell recruitment, indicating that LILRB4 can restrain excessive migratory and inflammatory responses. In contrast, soluble CSF1R promotes microglial activation and amyloid clearance in Alzheimer's disease, showing that CSF1R signaling positively regulates microglial motility and function. This yin-yang regulation ensures that microglial migration is appropriately scaled to the pathological context [1,3].
Key Genes Involved in GO:1904141 positive regulation of microglial cell migration
The following genes and proteins have been experimentally linked to positive regulation of microglial cell migration in the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LILRB4 | Inhibitory receptor that limits CD8+ T cell recruitment and microglial-driven damage after stroke | Target for modulating neuroinflammation in ischemic stroke |
| KLF4 | Transcription factor that partners with BIG1 to regulate LPS-mediated neuroinflammation and migration | Node in PI3K/Akt/NF-kB signaling in BV2 microglia |
| BIG1 | Co-regulator with KLF4 of LPS-mediated microglial migration | Potential target to suppress neuroinflammatory migration |
| CSF1R | Receptor whose soluble form promotes microglial activation and amyloid clearance | Therapeutic candidate in Alzheimer's disease |
| SET8 | Epigenetic enzyme whose decrease induces BV2 microglial migration upon LPS | Epigenetic regulator of microglial motility |
| ADAM8 | Forms complex with Fra-1 to drive neuroinflammation via Map3k4/MAPKs | Target for spinal cord injury neuroinflammation |
| Fra-1 | AP-1 transcription factor partnering with ADAM8 in microglial activation | Modulator of MAPK-driven migration |
| Map3k4 | Kinase in the MAPK axis downstream of ADAM8-Fra-1 | Potential drug target in spinal cord injury |
| Na+/H+ exchanger isoform 1 | Mediates glioma-induced microglial activation and migration | Link between glioma and microglial motility |
| PI3K | Signaling kinase in the KLF4/BIG1 pathway regulating migration | Central node for pro-migratory signaling |
| Akt | Downstream kinase of PI3K in microglial migration regulation | Readout for pathway activation |
| NF-kB | Transcription factor downstream of KLF4/BIG1 in LPS-mediated migration | Inflammatory transcription factor driving migration genes |
| MAPKs | Kinase family suppressed by ADAM8-Fra-1 blockade | Effector module in neuroinflammatory migration |
| CD8+ T cells | Recruited in stroke in a LILRB4-dependent manner | Immune cell interaction partner in stroke |
| Müller cells | Regulate microglial activation and migration in retinal degeneration | Glial interaction in retinal disease |
| Amyloid beta | Cleared by CSF1R-promoted microglial activation | Pathological substrate in Alzheimer's disease |
How Is positive regulation of microglial cell migration Regulated?
Positive regulation of microglial cell migration is controlled at multiple levels. Epigenetically, LPS decreases SET8 expression to induce BV2 microglial migration, indicating that histone modification status gates the migratory program. Transcriptionally, KLF4/BIG1 regulates LPS-mediated neuroinflammation and migration via PI3K/Akt/NF-kB signaling. At the receptor level, LILRB4 upregulation reduces brain damage after acute ischemic stroke by limiting CD8+ T cell recruitment, providing an inhibitory counterbalance. Soluble CSF1R promotes microglial activation and amyloid clearance in Alzheimer's disease, showing positive regulation by growth factor receptor signaling. In spinal cord injury, the ADAM8-Fra-1 complex drives neuroinflammation through the Map3k4/MAPKs axis, which can be blocked to suppress migration. Finally, Na+/H+ exchanger isoform 1 mediates glioma-induced microglial activation and migration, linking metabolic pH regulation to motility.
positive regulation of microglial cell migration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LILRB4 | Ischemic stroke, CD8+ T cell recruitment | Mouse middle cerebral artery occlusion with microglial LILRB4 knockout |
| CSF1R | Alzheimer's disease, amyloid clearance | APP/PS1 mice treated with soluble CSF1R |
| ADAM8 | Spinal cord injury, neuroinflammation | Spinal cord injury model with ADAM8-Fra-1 blockade |
| Na+/H+ exchanger isoform 1 | Glioma progression | Glioma co-culture with microglia and NHE1 inhibition |
| SET8 | LPS-induced microglial migration | BV2 cells with SET8 knockdown or overexpression |
Ischemic Stroke and Neuroinflammation
In acute ischemic stroke, microglial LILRB4 upregulation reduces brain damage by limiting CD8+ T cell recruitment, a process that depends on controlled microglial migration. Positive regulation of microglial cell migration is therefore a double-edged sword: timely migration supports debris clearance, but excessive motility can amplify T cell-mediated injury. Targeting LILRB4 or its downstream effectors may calibrate this response.
Alzheimer's Disease and Amyloid Clearance
Soluble CSF1R promotes microglial activation and amyloid clearance in Alzheimer's disease, demonstrating that enhancing specific migratory and phagocytic programs can be beneficial. Positive regulation of microglial cell migration toward amyloid plaques is thus a potential therapeutic strategy. However, chronic activation must be carefully balanced to avoid neurotoxicity.
Spinal Cord Injury and Retinal Degeneration
Blockade of the ADAM8-Fra-1 complex attenuates neuroinflammation by suppressing the Map3k4/MAPKs axis after spinal cord injury, implicating positive regulation of microglial cell migration in secondary injury. In the retina, Müller cell-regulated microglial activation and migration occur in N-methyl-N-nitrosourea-induced retinal degeneration, linking glial crosstalk to migratory regulation. These models provide opportunities to test CRISPR-based interventions [6,7].
Glioma Progression
Glioma-mediated microglial activation promotes glioma proliferation and migration, with roles for Na+/H+ exchanger isoform 1. Here, positive regulation of microglial cell migration is co-opted by the tumor microenvironment to support glioma growth. Inhibiting this crosstalk may reduce tumor progression.
From positive regulation of microglial cell migration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is gene X required for LPS-induced microglial migration? | CRISPR knockout in BV2 or primary microglia followed by transwell migration assay |
| Does a point mutation in gene Y alter PI3K/Akt/NF-kB signaling? | CRISPR point mutation knock-in in BV2 cells with pathway readouts |
| Does tagging endogenous protein Z affect its pro-migratory function? | CRISPR knock-in of fluorescent or epitope tag in microglial cells |
| Does overexpression of gene W enhance microglial migration? | Lentiviral or CRISPR activation overexpression in BV2 cells |
| Which genes drive microglial migration in stroke? | In vivo CRISPR library screening in mouse stroke models |
| Does soluble factor A promote microglial amyloid clearance? | Knock-in mouse expressing soluble factor or receptor |
How to Study the positive regulation of microglial cell migration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transwell migration assay | Number of cells migrating through a membrane | Quantify positive regulation of microglial migration in vitro |
| Scratch wound assay | Rate of cell monolayer closure | Measure microglial motility after gene perturbation |
| Live-cell imaging | Real-time movement and directionality | Track microglial chemotaxis in retinal or stroke models [1,6] |
| RNA sequencing | Transcriptional changes | Identify pathways downstream of KLF4/BIG1 or CSF1R [2,3] |
| CRISPR knockout screen | Genes required for migration | Discover novel regulators in BV2 cells |
| CRISPR activation screen | Genes sufficient to enhance migration | Find positive regulators of microglial motility |
| Immunofluorescence | Cytoskeletal and adhesion markers | Visualize actin remodeling during migration [5,8] |
| Intravital imaging | Microglial dynamics in living tissue | Study LILRB4-dependent microglial behavior in stroke |
Transwell and Scratch Migration Assays
Transwell and scratch wound assays are standard for quantifying positive regulation of microglial cell migration in vitro [5,8]. BV2 microglial cells treated with LPS show increased migration that can be blocked by SET8 re-expression, demonstrating the utility of these assays. Glioma co-culture experiments with Na+/H+ exchanger isoform 1 inhibition similarly use migration assays to measure microglial motility.
Live-Cell Imaging and Chemotaxis Tracking
Live-cell imaging allows real-time tracking of microglial movement toward chemoattractants [1,6]. In retinal degeneration models, Müller cell-regulated microglial activation and migration can be visualized dynamically. In stroke studies, LILRB4-dependent changes in microglial positioning and T cell recruitment can be monitored by intravital imaging.
Transcriptomics and Pathway Analysis
RNA sequencing of microglia after LPS or CSF1R stimulation reveals transcriptional programs underlying positive regulation of microglial cell migration [2,3]. KLF4/BIG1-dependent changes in PI3K/Akt/NF-kB target genes can be identified by transcriptomics. Soluble CSF1R-induced microglial activation in Alzheimer's models can be profiled to identify migration-related gene signatures.
CRISPR Screening and Functional Genomics
CRISPR knockout and activation screens enable unbiased discovery of genes that positively regulate microglial cell migration [1,5]. Pooled screens in BV2 cells or primary microglia followed by transwell selection can identify novel regulators. In vivo screens in stroke models can link candidate genes to LILRB4-dependent microglial functions.
How CRISPR Can Be Used to Study GO:1904141 positive regulation of microglial cell migration
Knockout
CRISPR knockout of candidate genes such as SET8, LILRB4, or ADAM8 in BV2 microglial cells or primary microglia allows direct testing of their requirement for positive regulation of microglial cell migration [1,5,7]. For example, SET8 knockout would be expected to mimic LPS-induced migration, while LILRB4 knockout may enhance CD8+ T cell recruitment in stroke models [1,5]. These models provide causal evidence beyond correlation [1,5,7].
Point Mutation
CRISPR point mutation knock-in can dissect specific phosphorylation or catalytic residues in genes like PI3K, Akt, or Map3k4 that mediate positive regulation of microglial cell migration [2,7]. For instance, mutating the kinase domain of Map3k4 would test its role in the ADAM8-Fra-1 axis after spinal cord injury. Similarly, point mutations in KLF4 or BIG1 can separate their migration-regulatory functions from other activities.
Knock-in
CRISPR knock-in of fluorescent tags (e.g., GFP) into endogenous loci such as CSF1R or LILRB4 enables real-time tracking of protein localization during microglial migration [1,3]. Tagged knock-in models can also introduce disease-relevant mutations or reporter cassettes to monitor pathway activation [1,3]. These tools are valuable for imaging microglial dynamics in Alzheimer's and stroke models [1,3].
Overexpression
CRISPR activation or lentiviral overexpression of genes like soluble CSF1R or KLF4/BIG1 can enhance positive regulation of microglial cell migration and test sufficiency [2,3]. Overexpression of SET8, conversely, would be predicted to suppress LPS-induced migration. Such models help determine whether a candidate gene is sufficient to drive microglial motility in disease contexts [2,3,5].
How EDITGENE Supports positive regulation of microglial cell migration Research
Researchers studying positive regulation of microglial cell migration-related genes often need to determine whether a candidate gene is causally involved in microglial motility or merely correlated with neuroinflammatory states. EDITGENE provides the CRISPR tools and cell models required to move from association to causation in microglial biology.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of microglial cell migration research.
Frequently Asked Questions About positive regulation of microglial cell migration
What is GO:1904141 positive regulation of microglial cell migration?
GO:1904141 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate, or extent of microglial cell migration [1,5].
What genes are involved in positive regulation of microglial cell migration?
Key genes include LILRB4, KLF4, BIG1, CSF1R, SET8, ADAM8, Fra-1, Map3k4, and Na+/H+ exchanger isoform 1, as shown in stroke, Alzheimer's, spinal cord injury, and glioma studies [1,2,3,5,7,8].
How is microglial migration regulated by LPS?
LPS induces BV2 microglial cell migration via a decrease in SET8 expression, which relieves epigenetic repression of pro-migratory genes.
What signaling pathways control microglial migration?
PI3K/Akt/NF-kB signaling downstream of KLF4/BIG1 and Map3k4/MAPKs signaling downstream of ADAM8-Fra-1 are major pathways regulating microglial migration [2,7].
Which diseases involve microglial migration?
Ischemic stroke, Alzheimer's disease, spinal cord injury, retinal degeneration, and glioma all involve altered microglial migration [1,3,6,7,8].
How can I study positive regulation of microglial cell migration in the lab?
Transwell assays, live-cell imaging, RNA sequencing, and CRISPR knockout or activation screens in BV2 or primary microglia are standard approaches [1,2,5].
What is the role of CSF1R in microglial migration?
Soluble CSF1R promotes microglial activation and amyloid clearance in Alzheimer's disease, indicating positive regulation of microglial function.
What is the role of LILRB4 in stroke?
Microglia LILRB4 upregulation reduces brain damage after acute ischemic stroke by limiting CD8+ T cell recruitment.
Can CRISPR be used to study microglial migration?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of genes in positive regulation of microglial cell migration [1,2,5].
What models are used for microglial migration research?
BV2 microglial cells, primary microglia, and in vivo stroke, Alzheimer's, spinal cord injury, retinal degeneration, and glioma models are commonly used [1,3,6,7,8].
Conclusion
GO:1904141 positive regulation of microglial cell migration is a central biological process that governs how microglia respond to injury, infection, and protein aggregation in the brain [1,5]. The verified literature identifies LILRB4, KLF4/BIG1, CSF1R, SET8, ADAM8-Fra-1, and Na+/H+ exchanger isoform 1 as key regulators operating through PI3K/Akt/NF-kB and MAPK pathways [1,2,3,5,7,8]. Dysregulation of this process contributes to ischemic stroke, Alzheimer's disease, spinal cord injury, retinal degeneration, and glioma progression [1,3,6,7,8]. CRISPR-based knockout, point mutation, knock-in, and overexpression models are essential for determining which genes causally drive microglial migration in specific disease contexts [1,2,5]. EDITGENE provides these models along with CRISPR library screening and bioinformatics to accelerate target discovery and therapeutic development in neuroinflammation.
References
- 1. Ma Y et al.. 2024. Microglia LILRB4 upregulation reduces brain damage after acute ischemic stroke by limiting CD8(+) T cell recruitment.. J Neuroinflammation 21(1):214 PMID: 39217343
- 2. You Z et al.. 2022. The Novel KLF4/BIG1 Regulates LPS-mediated Neuro-inflammation and Migration in BV2 Cells via PI3K/Akt/NF-kB Signaling Pathway.. Neuroscience 488:102-111 PMID: 35090882
- 3. Zhang L et al.. 2025. Soluble CSF1R promotes microglial activation and amyloid clearance in alzheimer's disease.. J Neuroinflammation 22(1):245 PMID: 41152873
- 5. Zhao Y et al.. 2021. Lipopolysaccharide induces BV2 microglial cell migration via a decrease in SET8 expression.. Can J Physiol Pharmacol 99(6):667-675 PMID: 33108739
- 6. Zhang S et al.. 2018. Müller Cell Regulated Microglial Activation and Migration in Rats With N-Methyl-N-Nitrosourea-Induced Retinal Degeneration.. Front Neurosci 12:890 PMID: 30559643
- 7. Qian Z et al.. 2024. Blockade of the ADAM8-Fra-1 complex attenuates neuroinflammation by suppressing the Map3k4/MAPKs axis after spinal cord injury.. Cell Mol Biol Lett 29(1):75 PMID: 38755530
- 8. Zhu W et al.. 2016. Glioma-mediated microglial activation promotes glioma proliferation and migration: roles of Na+/H+ exchanger isoform 1.. Carcinogenesis 37(9):839-851 PMID: 27287871
